Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine H Wilson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biochemical Society Transactions|July 19, 2013
Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinaseJason S Kerr, Catherine H Wilson
Frontiers in Cell and Developmental Biology|April 5, 2024
Manipulating Myc for reparative regenerationCamilla Ascanelli, Rowda Dahir, Catherine H Wilson
Biochemical Society Transactions|September 4, 2025
Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatmentChristopher A P Batho, James E Hudson, Catherine H Wilson
Journal of Molecular Signaling|March 5, 2011
Activation of K-RAS by co-mutation of codons 19 and 20 is transformingAdam Naguib, Catherine H Wilson, David J Adams, et al.
Nucleic Acids Research|June 16, 2025
A flexible, high-throughput system for studying live mRNA translation with HiBiT technologyCamilla Ascanelli, Elsa Lawrence, Christopher A P Batho, et al.
The Journal of Investigative Dermatology|December 24, 2005
Numerous keratinocyte subtypes involved in wound re-epithelializationGirish K Patel, Catherine H Wilson, Keith G Harding, et al.
Journal of Lipid Research|August 6, 2020
Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancerZoe Hall, Catherine H Wilson, Deborah L Burkhart, et al.
Nature Communications|January 9, 2021
Disease risk scores for skin cancersPierre Fontanillas, Babak Alipanahi, Nicholas A Furlotte, et al.
Cancer Research|June 24, 2016
Myc Expression Drives Aberrant Lipid Metabolism in Lung CancerZoe Hall, Zsuzsanna Ament, Catherine H Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modelingPeter Kreuzaler, Matthew A Clarke, Elizabeth J Brown, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biochemical Society Transactions|July 19, 2013
Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinaseJason S Kerr, Catherine H Wilson
Frontiers in Cell and Developmental Biology|April 5, 2024
Manipulating Myc for reparative regenerationCamilla Ascanelli, Rowda Dahir, Catherine H Wilson
Biochemical Society Transactions|September 4, 2025
Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatmentChristopher A P Batho, James E Hudson, Catherine H Wilson
Journal of Molecular Signaling|March 5, 2011
Activation of K-RAS by co-mutation of codons 19 and 20 is transformingAdam Naguib, Catherine H Wilson, David J Adams, et al.
Nucleic Acids Research|June 16, 2025
A flexible, high-throughput system for studying live mRNA translation with HiBiT technologyCamilla Ascanelli, Elsa Lawrence, Christopher A P Batho, et al.
The Journal of Investigative Dermatology|December 24, 2005
Numerous keratinocyte subtypes involved in wound re-epithelializationGirish K Patel, Catherine H Wilson, Keith G Harding, et al.
Journal of Lipid Research|August 6, 2020
Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancerZoe Hall, Catherine H Wilson, Deborah L Burkhart, et al.
Nature Communications|January 9, 2021
Disease risk scores for skin cancersPierre Fontanillas, Babak Alipanahi, Nicholas A Furlotte, et al.
Cancer Research|June 24, 2016
Myc Expression Drives Aberrant Lipid Metabolism in Lung CancerZoe Hall, Zsuzsanna Ament, Catherine H Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modelingPeter Kreuzaler, Matthew A Clarke, Elizabeth J Brown, et al.
Pageof 3